Page 76 - Revista SPORL - Vol 44. Nº3
P. 76
PATRÍCIA MELO, ISABEL GUERREIRO, Mº MANUEL HENRIQUES, JOSÉ COSTA QUINTA
11 Chiu AG, Newkirk KA, Davidson BJ, Bur-
ningham AR, Krowiak EJ, Deeb ZE. An-
Vleeming W, Amsterdam J, Stricker BH, giotensin-converting enzyme inhibitor-in-
Wildt DJ. ACE inhibitor-induced angioe- duced ongioedema: o multicenter review
demo: incidence, prevention and manage- ond an algorithm for airway management.
ment. Drug Safety. 1998; 18: 171-188. Ann Otol Rhinol loryngol. 2001 ; 1 10:
Agah R, Bandi V, Guntupolli KK. Angioe- 834-840.
demo: the role of ACE inhibitors and Fac 12 Ishoo E, Shah UK, Grillone GA, Strum JR,
tors associated with poor clinical outcome. Fuleihon NS. Predicting airway risk in an-
Intensive Care Med. 1997; 23: 793-796.
gioedema: staging system based on pre-
Quincke H. Uber akutes umschreibenes
sentation. Otolaryngol Head Neck Surg.
hautodem. Monotsschr Prakt Dermatol.
1999; 121: 263-268.
1882; 1: 129.
13 Sondhi D, Lippmonn M, Muroli G. Airway
Osler W. Hereditary angioneurotic oede-
compromise due to ongiotensin-converting
mo. AmJ Med Sci. 1988; 95: 362.
enzyme inhibitor-induced ongioedemo.
80in KD, Butler BK, Grobbeloor E, Rob-
Chest. 2004; 126: 400404.
son AK. An overview of the acute presen-
14 Karim MY, Mosood A. Fresh—Írozen plos-
tation and early management of angioe-
mo os (: treatment for life-rhreatning ACE-
demo in otolaryngology practice. CME
inhibitor ongioedema. J Allergy Clin Im-
Bulletin Otolaryngol Head Neck Surg.
munol. 2002; 109: 370-371.
2004; 8:13-17.
15 Worrier MR, Copilevitz CA, Dykewicz
Pracy JP, McGlashan JA, Walsh RM, Gle-
MS, Slavin RG. Fresh frozen plasma in
eson Ml. Angioedema secondary to an-
the treatment of resistant angiotensin—con-
giotensin-converting enzyme inhibitors. J
verting enzyme inhibitor angioedema. Ann
Laryngol Otol. 1994; 108: ó9ó—ó98.
Allergy Asthma Immunol. 2004; 92:
Rudy E. Update: drug—induced angioede
573-575.
me without urticaria. Drug Therapy Topics.
16 Bentsianov BL, Porhiscar A, Azer M, Hor-
2004; 33-37.
-E| G. The role of fiberoptic nasophoryn-
Wilkin JK, Hammond JJ, Kirkendoll WM.
goscopy in the management of the acute
The captopril—induced eruption. A possible
airway in ongioneurotic edema. Laryn-
mechanism: cutaneous kinin potentiotion.
goscope. 2000; 110: 2016-2019.
Arch Dermatol. 1980; 1 16: 902-905.
17 Cohen EG, Solimon AM. Changing trends
Chiu AG, Krowiok E1, Deeb ZE. Angioe-
demo associated with angiotensin II recep in ongioedemo. Ann Otol Rhinol Laryn-
tor antagonists: challenging our knowledge 901. 2001; 110: 701-706.
of angioedemo ond its etiology. Laryngos- 18 Zouli D, Contestcbile S, Grossi A, Borto-
cope. 2001; 111: 1729-1731. Iotti R, Ballardini G, Bianchi FB. ACE-
10 Schiller Pl, Messmer I., Haefeli WE, Scli- -inhibitors and cngioedema. J Allergy Clin
enger RG, Bircher Al. Angiotensin-con- Immunol. 2002; 110: 538-539.
vetting enzyme inhibitor—induced ongioe 19 Zirkle M, Bhottochoryya N. Predictors of
demo: late onset, irregular course and po oirwoy intervention in ongioedemo of the
tential role of triggers. Allergy. 1997: head ond neck. Otolaryngol Head Neck
52: 432-435. Surg. 2000; 123: 240245.
—— 306
